During yet another heated exchange at a Senate committee hearing on Thursday, Sen. Paul (R-Kentucky) argued that Fauci’s agency, the National Institute of Allergy and Infectious Diseases (NIAID), approved funding for risky “gain of function” research at the Wuhan lab, and that the health adviser should acknowledge doing so and …
Read More »